InsiderTrades.com logo
Jack Phillips net worth and biography
  • LinkedIn
  • Phone
  • Email
  • Website

Jack Phillips Biography and Net Worth

CEO of Accelerate Diagnostics
Jack Phillips has served as President and Chief Executive Officer of Accelerate Diagnostics since February 2020. Mr. Phillips joined the company in September of 2019 as Chief Operating Officer. From 2010 to 2019, Mr. Phillips served as President and CEO of Roche Diagnostics North America, the world leader in in-vitro diagnostics. During this time, Jack also served as a member of the Roche Global Diagnostics Leadership Team. Before joining Roche Diagnostics, Mr. Phillips served as Senior Vice President of Commercial Operations, North America at Ventana Medical Systems, a member of the Roche Group, and the world leader in tissue-based cancer diagnostics. Mr. Phillips has also served in commercial leadership roles at Bayer Diagnostics and Motorola. He serves as a member of the AdvaMedDx Board of Directors in Washington, D.C. and previously served as Chairman of the Board for Central Indiana Corporate Partnership in Indianapolis, IN.

What is Jack Phillips' net worth?

The estimated net worth of Jack Phillips is at least $6.51 thousand as of April 4th, 2025. Mr. Phillips owns 191,374 shares of Accelerate Diagnostics stock worth more than $6,507 as of May 9th. This net worth approximation does not reflect any other investments that Mr. Phillips may own. Learn More about Jack Phillips' net worth.

How do I contact Jack Phillips?

The corporate mailing address for Mr. Phillips and other Accelerate Diagnostics executives is 3950 South Country Club Suite 470, Tucson AZ, 85714. Accelerate Diagnostics can also be reached via phone at (520) 365-3100 and via email at [email protected]. Learn More on Jack Phillips' contact information.

Has Jack Phillips been buying or selling shares of Accelerate Diagnostics?

Jack Phillips has not been actively trading shares of Accelerate Diagnostics over the course of the past ninety days. Most recently, Jack Phillips sold 25,343 shares of the business's stock in a transaction on Friday, April 4th. The shares were sold at an average price of $0.65, for a transaction totalling $16,472.95. Following the completion of the sale, the chief executive officer now directly owns 191,374 shares of the company's stock, valued at $124,393.10. Learn More on Jack Phillips' trading history.

Who are Accelerate Diagnostics' active insiders?

Accelerate Diagnostics' insider roster includes Hany Massarany (Director), Jack Phillips (CEO), Ron Price (Insider), Steven Reichling (CFO), and Jack Schuler (Director). Learn More on Accelerate Diagnostics' active insiders.

Jack Phillips Insider Trading History at Accelerate Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
4/4/2025Sell25,343$0.65$16,472.95191,374View SEC Filing Icon  
4/17/2024Sell26,735$0.78$20,853.30162,919View SEC Filing Icon  
4/12/2024Sell26,545$0.86$22,828.70129,726View SEC Filing Icon  
4/4/2024Sell15,887$0.88$13,980.5696,343View SEC Filing Icon  
2/1/2024Sell494$1.30$642.2076,707View SEC Filing Icon  
12/13/2023Sell739$4.39$3,244.2159,535View SEC Filing Icon  
10/13/2023Sell734$5.83$4,279.2257,576View SEC Filing Icon  
9/13/2023Sell733$6.53$4,786.4956,589View SEC Filing Icon  
8/14/2023Sell751$6.80$5,106.8055,600View SEC Filing Icon  
7/13/2023Sell729$6.90$5,030.1054,629View SEC Filing Icon  
6/22/2023Sell2,726$7.10$19,354.6053,636View SEC Filing Icon  
6/13/2023Sell839$9.00$7,551.0050,146View SEC Filing Icon  
5/15/2023Sell794$6.90$5,478.6049,263View SEC Filing Icon  
4/13/2023Sell744$6.50$4,836.0048,336View SEC Filing Icon  
3/13/2023Sell745$4.90$3,650.5047,358View SEC Filing Icon  
3/8/2023Sell15,563$4.70$73,146.1046,382View SEC Filing Icon  
2/13/2023Sell860$6.00$5,160.0026,945View SEC Filing Icon  
1/13/2023Sell840$6.90$5,796.0025,084View SEC Filing Icon  
6/22/2022Sell2,819$9.10$25,652.9024,203View SEC Filing Icon  
4/28/2022Sell8,370$9.80$82,026.0020,807View SEC Filing Icon  
2/1/2022Sell365$32.60$11,899.00View SEC Filing Icon  
6/22/2021Sell2,347$79.40$186,351.8013,617View SEC Filing Icon  
5/13/2021Sell2,506$67.60$169,405.609,908View SEC Filing Icon  
See Full Table

Jack Phillips Buying and Selling Activity at Accelerate Diagnostics

This chart shows Jack Phillips's buying and selling at Accelerate Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Accelerate Diagnostics Company Overview

Accelerate Diagnostics logo
Accelerate Diagnostics, Inc., an in vitro diagnostics company, provides solutions for the diagnosis of serious infections in the United States, Europe, and the Middle East. The company offers Accelerate Pheno system, an in vitro diagnostic platform for the identification and antibiotic susceptibility testing of pathogens associated with serious or health care-associated infections, including gram-positive and gram-negative organisms. It also provides the Accelerate PhenoTest, a test kit for the system, which provides identify and antibiotic susceptibility testing results for patients suspected of bacteremia or fungemia, both life-threatening conditions with high morbidity and mortality risk. The company was formerly known as Accelr8 Technology Corporation and changed its name to Accelerate Diagnostics, Inc. in December 2012. Accelerate Diagnostics, Inc. was incorporated in 1982 and is headquartered in Tucson, Arizona.
Read More

Today's Range

Now: $0.03
Low: $0.03
High: $0.03

50 Day Range

MA: $0.65
Low: $0.03
High: $1.18

2 Week Range

Now: $0.03
Low: $0.03
High: $0.59

Volume

N/A

Average Volume

6,477,235 shs

Market Capitalization

$857.14 thousand

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.22